Stimcell Energetics (STME) Profit After Tax (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 70.76% |
| Nov 30, 2025 | -16.62% |
| Aug 31, 2025 | -21.10% |
| May 31, 2025 | -56.06% |
| Feb 28, 2025 | -0.74% |
| Nov 30, 2024 | -108.47% |
| Aug 31, 2024 | 46.45% |
| May 31, 2024 | -204.16% |
| Feb 29, 2024 | 298.15% |
| Nov 30, 2023 | 21.32% |
| Aug 31, 2023 | 3.06% |
| May 31, 2023 | 32.82% |
| Feb 28, 2023 | 17.26% |
| Nov 30, 2022 | 7.67% |
| Aug 31, 2022 | 4.84% |
| May 31, 2022 | -36.05% |
| Feb 28, 2022 | 32.10% |
| Nov 30, 2021 | 26.48% |
| Aug 31, 2021 | -27.57% |
| May 31, 2021 | -4.82% |
| Feb 28, 2021 | 5.45% |
| Nov 30, 2020 | 5.90% |
| Aug 31, 2020 | 20.10% |
| May 31, 2020 | 2.70% |
| Feb 29, 2020 | 14.72% |
| Nov 30, 2019 | -23.73% |
| Aug 31, 2019 | 79.61% |
| May 31, 2019 | -207.95% |
| Feb 28, 2019 | -206.36% |
| Nov 30, 2018 | 47.62% |
| Aug 31, 2018 | -3.02% |
| May 31, 2018 | 20.11% |
| Feb 28, 2018 | -63.08% |
| Nov 30, 2017 | 78.23% |
| Aug 31, 2017 | -311.46% |
| May 31, 2017 | 229.38% |
| Feb 28, 2017 | 71.27% |
| Nov 30, 2016 | -280.21% |
| Aug 31, 2016 | 16.54% |
| May 31, 2016 | -12.86% |
| May 31, 2013 | 76.31% |
| Feb 28, 2013 | -31.76% |
| May 31, 2012 | 44.20% |
| Feb 29, 2012 | 30.14% |
| Nov 30, 2011 | -64.53% |
| Aug 31, 2011 | -167.79% |